Predictive model for non-malignant portal vein thrombosis associated with cirrhosis based on inflammatory biomarkers

Table 3 The results of univariate and multivariate analysis

Characteristics	Univariate analysis			Multivariate analysis
	OR	CI	P value	OR	CI	P value
Etiology
AIH	Reference			Reference
Hepatitis	1.890	1.066-3.350	0.029	1.772	0.869-3.613	0.115
Others	3.348	1.749-6.408	0.000	2.893	1.309-6.395	0.009
Ascites
No	Reference			Reference
Yes	4.394	3.043-6.346	0.000	2.007	1.27-3.174	0.003
GOV
No	Reference			Reference
Yes	13.660	6.165-30.266	0.000	5.844	2.385-14.321	0.000
ANRI
< 48	Reference			Reference
≥ 48	0.418	0.257-0.677	0.000	0.457	0.249-0.839	0.011
INR
< 1.27	Reference			Reference
≥ 1.27	2.646	1.887-3.710	0.000	1.389	0.722-2.672	0.326
PLR
≤ 68.06	Reference			Reference
> 68.06	1.846	1.305-2.610	0.001	2.308	1.474-3.615	0.000
ALB, g/L
< 43	Reference			Reference
≥ 43	0.292	0.185-0.460	0.000	0.700	0.387-1.269	0.240
D-D, μg/mL
≤ 2.52	Reference			Reference
> 2.52	4.860	3.345-7.059	0.000	2.795	1.805-4.33	0.000
PLT, × 109/L
< 85	Reference			Reference
≥ 85	0.420	0.286-0.615	0.000	0.520	0.306-0.884	0.016
PT, s
< 14.4	Reference			Reference
≥ 14.4	2.458	1.755-3.442	0.000	1.279	0.67-2.441	0.456
PVD, mm
< 14.5	Reference			Reference
≥ 14.5	3.613	2.509-5.202	0.000	2.110	1.345-3.31	0.001
PVV, cm/s
< 20.05	Reference			Reference
≥ 20.05	0.515	0.369-0.718	0.000	0.640	0.424-0.965	0.033
SVD, mm
< 8	Reference			Reference
≥ 8	3.680	2.511-5.394	0.000	1.281	0.772-2.128	0.338

AIH: Autoimmune hepatitis; GOV: Gastroesophageal varices; ANRI: Aspartate transaminase to neutrophil ratio index; INR: International normalized ratio; PLR: Platelet-to-lymphocyte ratio; ALB: Albumin; D-D: D-dimer; PLT: Platelet count; PT: Prothrombin time; PVD: Portal vein diameter; PVV: Portal vein velocity; SVD: Splenic vein diameter.